March 19, 2026 a 08:38 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc., a pioneer in minimally invasive care, continues to be a dominant force in the healthcare sector with its flagship product, the da Vinci Surgical System. The company’s commitment to enhancing surgical precision and accessibility is reflected in its consistent strong performance. The latest analyst ratings indicate a positive outlook with opportunities for robust growth, although the emergence of competitive technologies remains a factor to watch.
Historical Stock Grades
The latest data for Intuitive Surgical, Inc. from March 2026 shows a predominant sentiment towards "Buy" ratings. Below is a detailed tabulation of the current analyst recommendations:
| Recommendation | Count | Visual Score |
|---|---|---|
| Strong Buy | 8 | |
| Buy | 17 | |
| Hold | 10 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
The analyst sentiment for Intuitive Surgical shows significant consistency with a maintained "Buy" stance, complemented by a slight fluctuation in "Hold" ratings over the past year. Key observations include:
- Total recommendations have grown, reaching peaks in recent months.
- Stable number of "Strong Buy" ratings, suggesting sustained confidence in the company's future.
- Noticeable increase in "Buy" recommendations, while "Hold" remains relatively stable.
Percentage Trends
A breakdown of analyst ratings indicates a lean towards favorable investment sentiments, though cautiously balanced by some "Hold" positions:
- Strong Buy ratings have remained relatively stable, hovering around 25%.
- Buy recommendations currently constitute about 53%, indicating broad confidence.
- Hold recommendations have shown minor variations, suggesting some market caution.
- Insignificant percentage changes in "Sell" and "Strong Sell" categories.
From the past year, the transition towards "Buy" indicates rising positive sentiment despite market uncertainties.
Latest Analyst Recommendations
Recent changes in analyst recommendations reflect a consolidated buy-side sentiment for ISRG:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-17 | Neutral | Neutral | UBS |
| 2026-03-11 | Buy | Neutral | Citigroup |
| 2026-02-24 | Neutral | Neutral | UBS |
| 2026-01-27 | Buy | Hold | Freedom Capital Markets |
| 2026-01-26 | Overweight | Overweight | Barclays |
Analyst Recommendations with Change of Opinion
Observations of shifts in analyst sentiment are crucial for assessing market direction:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-03-11 | Buy | Neutral | Citigroup |
| 2026-01-27 | Buy | Hold | Freedom Capital Markets |
| 2025-12-11 | Neutral | Buy | Citigroup |
| 2025-06-09 | Sell | Hold | Deutsche Bank |
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
Interpretation
The current analyst sentiment showcases a high level of confidence in ISRG’s market positioning. Rising "Buy" ratings indicate optimism towards its technological advancements and expansion strategies. However, the persistence of "Hold" ratings suggests some caution in light of economic volatilities or competition. Minimal changes in "Sell" recommendations imply a stable confidence in maintaining positions, yet further monitoring of market trends is advisable for maintaining competitiveness.
Conclusion
Intuitive Surgical, Inc. stands at a promising juncture with a firm analyst backing that hints at potential upward movements in share value. Stakeholders should view this as a period of opportunity, while remaining vigilant of sector shifts and emerging technologies. As analyst sentiments gradually incline towards positive recommendations, ISRG's robust fundamentals could translate into profitable gains if managed strategically. Conversely, the slight uptick in "Hold" underscores the necessity for careful observation of market dynamics and potential headwinds.